TRANSITION SERVICES AGREEMENT by and between ALKERMES, INC. and MURAL ONCOLOGY, INC. Dated as of [•], 2023Transition Services Agreement • September 22nd, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 22nd, 2023 Company Industry JurisdictionThis TRANSITION SERVICES AGREEMENT (this “Agreement”), dated as of [•], 2023 (the “Effective Date”), is entered into by and between Alkermes, Inc., a Pennsylvania corporation and wholly owned indirect subsidiary of Alkermes plc (“Alkermes US”), and Mural Oncology, Inc., a Delaware corporation and, following the Separation, a wholly owned direct subsidiary of Mural Oncology plc (“Mural US”). “Party” or “Parties” means Alkermes US or Mural US, individually or collectively, as the case may be.
SEPARATION AGREEMENT by and between ALKERMES PLC and MURAL ONCOLOGY PLC Dated as of [•], 2023Separation Agreement • September 22nd, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 22nd, 2023 Company Industry JurisdictionThis SEPARATION AGREEMENT (this “Agreement”), dated as of [•], 2023, is entered into by and between Alkermes plc, an Irish public limited company (“Alkermes”), Mural Oncology plc, an Irish public limited company (“Mural”), and, solely with respect to Article II, Section 4.5 and Section 7.12, Mural Oncology, Inc., a Delaware corporation (“Mural US”). “Party” or “Parties” means Alkermes, Mural or Mural US, individually or collectively, as the case may be. Each capitalized term used and not elsewhere defined herein has the meaning set forth in Section 1.1.
TAX MATTERS AGREEMENT by and between ALKERMES PLC and MURAL ONCOLOGY PLC Dated as of [●], 2023Tax Matters Agreement • September 22nd, 2023 • Mural Oncology PLC • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 22nd, 2023 Company Industry JurisdictionThis TAX MATTERS AGREEMENT (this “Agreement”) is entered into as of [•], 2023, by and between Alkermes plc, an Irish public limited company (“Alkermes”), and Mural Oncology plc, an Irish public limited company (“Mural”). (Alkermes and Mural are sometimes collectively referred to herein as the “Parties” and, as the context requires, individually referred to herein as a “Party”).